Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Single orphan document will simplify process for industry

March 1, 2010 Research and Development EMA, FDA, Orphan

The FDA and European Medicines Agency are to simplify the regulatory process for orphan medicines by agreeing to accept a …
News
ICON headquarters

ICON sees revenues rise in 2009

March 1, 2010 Research and Development CRO, ICON

Contract research organisation ICON saw its revenues increase 3% to $888 million last year and says it is “positive, though …
News

Quotient Clinical receives MHRA Supplementary Accreditation

February 26, 2010 Research and Development Quotient

 This is one of the highest levels of accreditation in Europe and confirms that Quotient Clinical is qualified to perform …
Feature
Case study
Press release

Government ups the ante in dementia research

February 26, 2010 Research and Development Alzheimer's, dementia

The government has attempted to ‘up the ante’ in dementia research by convening a ministerial group comprising charities, scientists, research …
News

Avastin study in ovarian cancer meets primary endpoint

February 25, 2010 Research and Development Cancer, avastin, ovarian

Preliminary results from a trial of Roche’s Avastin in advanced ovarian cancer suggest that the drug lengthens progression-free survival when …
News

Sanofi’s breast cancer candidate tipped for future success

February 25, 2010 Research and Development, Sales and Marketing BSI-201, Sanofi-Aventis, breast cancer

A Sanofi-Aventis drug currently in phase III has been predicted as a future blockbuster in breast cancer treatment. Sanofi’s BSI-201 …
News

Avastin fails in phase III study

February 24, 2010 Research and Development Roche, avastin, gastric cancer, stomach cancer

Roche’s Avastin does not help patients with a severe form of stomach cancer to live longer, according to the results …
News

Methylene blue poised to move into the clinic

February 24, 2010 Manufacturing and Production, Research and Development Novasep, ProveBlue, Provepharm, malaria

A new purer form of the reagent methylene blue could take the compound out of the testing laboratory and into …
News
IcahnWebV

Predatory Icahn moves in on weakened Genzyme

February 23, 2010 Research and Development, Sales and Marketing Gaucher, Genzyme, Icahn

Corporate raider Carl Icahn has made a bid to gain control of beleaguered Genzyme as it struggles to overcome major …
News
Avandia

Reports raise fresh Avandia safety questions

February 23, 2010 Research and Development, Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline’s troubled diabetes drug Avandia has been hit by fresh reports from the US that it increases the risk of …
News

Pfizer, Lilly and Merck partner for cancer research

February 23, 2010 Research and Development Asia, Cancer, developing world, em, emerging markets

Three pharma companies have formed a not-for-profit organisation, the Asian Cancer Research Group (ACRG), to boost work on treating common …
News

Digital Pharma: Searching for clinical trials

February 23, 2010 Research and Development CRO, TrialReach, digi, digital pharma, digital pharma research, digital research, patient recruitment

A new clinical trials search and referral engine has launched to help patients who are considering taking part in a …
Feature

Chiltern Announces Partnership with Charles River

February 23, 2010 Research and Development

News
Press release

Lilly UK appoints Ramona Sequeira managing director

February 23, 2010 Research and Development, Sales and Marketing appointment, lilly, research and development, sales and marketing

Lilly UK has appointed Ramona Sequeira managing director, UK and Republic of Ireland.She replaces Andrew Hotchkiss who becomes vice president …
Appointment
Brain picture

Novartis gains edge in MS treatment race

February 22, 2010 Research and Development, Sales and Marketing Cladribine, Gilenia, MS, Novartis

Novartis’ new oral multiple sclerosis treatment Gilenia will be given a priority review by the FDA.This could lead to a …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025